Proactive and efficient way to identify IPG and ICD patients who are getting a device replacement and meet CRT therapy indications based on clinical evidence and guidelines.
|The ScreenCRT application is a tool for healthcare professionals to identify implanted IPG and ICD patients with high % RVP and who are nearing time of device replacement. Patients that meet these criteria, would potentially benefit of a CRT upgrade based on the latest ESC guidelines.|
The ScreenCRT application provides the automatic identification at a clinic level of patients receiving an ICD or IPG therapy that might benefit from a CRT therapy. This is done by analyzing the last 13 weeks of Cardiac Compass® data and raising attention on those with a high right ventricular percentage.
The application allows the user to review the patients and get some useful information such as the time elapsed since the implant, the activity level, the MVP mode status, pacing settings and the device battery status.
- Last update16/10/2014
- Available inWestern Europe
- Supported devicesAll ICD and IPG devices except for Ensura DR MRI™ and those belonging to Chronicle, EnRhythm and pre Gen1 families.